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Plasticity Genes Do Not Modify Associations Between Physical Activity
and Depressive Symptoms
N. Stavrakakis, A. J. Oldehinkel, E. Nederhof,
and R. C. Oude Voshaar
University of Groningen
F. C. Verhulst
Sophi Children’s Hospital, Rotterdam, The Netherlands
J. Ormel and P. de Jonge
University of Groningen
Objective: Physical activity is inversely associated with depression in adolescents, but the overall
associations are fairly weak, suggesting individual differences in the strength of the associations. The aim
of this study was to investigate whether plasticity genes modify the reciprocal prospective associations
between physical activity and depressive symptoms found previously. Methods: In a prospective
population-based study (N  1,196), physical activity and depressive symptoms were assessed three
times, around the ages of 11, 13.5, and 16. Structural Equation Modeling was used to examine reciprocal
effects of physical activity and depressive symptoms over time. The plasticity genes examined were
5-HTTLPR, DRD2, DRD4, MAOA, TPH1, 5-HTR2A, COMT, and BDNF . A cumulative gene plasticity
index consisting of three groups (low, intermediate, and high) according to the number of plasticity
alleles carried by the adolescents was created. Using a multigroup approach, we examined whether the
associations between physical activity and depressive symptoms differed between the three cumulative
plasticity groups, as well as between the individual polymorphisms. Results: We found significant
cross-sectional and cross-lagged paths from physical activity to depressive symptoms and vice versa.
Neither the cumulative plasticity index nor the individual polymorphisms modified the strengths of these
associations. Conclusion: Associations between adolescents’ physical activity and depressive symptoms
are not modified by plasticity genes.
Keywords: physical activity, depressive symptoms, plasticity genes, genes, adolescents
Individuals carrying specific genotypes have a higher sensitivity
to environmental influences than others (Belsky et al., 2009).
Although research initially focused on the negative consequences
of these genotypes in the context of the classic diathesis-stress
framework, more recent work stresses the possibility that individ-
uals who suffer most from negative experiences might also benefit
most from environmental support or the absence of adversity
(Belsky & Beaver, 2011; Ellis, Boyce, Belsky, Bakermans-
Kranenburg, & van Ijzendoorn, 2011). This “for better and for
worse” manner in which individuals are more responsive to envi-
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ronmental influences suggests that individuals who carry specific
genotypes might benefit more from positive environmental influ-
ences (such as family or social support) in early life, while they
might also be more vulnerable to negative environmental influ-
ences (such as child maltreatment and negative life events) in
developing psychopathology later on. Genes thought to be respon-
sible for this differential susceptibility have been labeled plasticity
genes.
Belsky and Pluess (2009) proposed several genes to operate as
plasticity genes including the serotonin transporter gene (SCL6A4),
the dopamine receptor 2 and 4 genes (DRD2 & DRD4), the
dopamine transporter gene (DAT1), the serotonin 2a receptor gene
(5HT2RA), the catechol-O-methyl transferase gene (COMT), the
monoamine oxidase gene (MAOA), and the tryptophan hydroxy-
lase 1 gene (TPH1). Although these genes are not the only likely
candidates, they have been shown most consistently to act as
plasticity genes in the literature (for a review, see Belsky & Pluess,
2009). Belsky and Pluess proposed a cumulative genetic plasticity
model, in which the susceptibility to particular environmental
influences is hypothesized to increase with increasing numbers of
plasticity alleles (Belsky et al., 2009; Belsky & Beaver, 2011).
In adults, inverse associations between physical activity (PA)
and depressive symptoms have been shown previously (Penedo &
Dahn, 2005), supporting the idea that engaging in PA can at least
prevent the development of depressive symptoms. In adolescents,
fewer studies have investigated this relationship, and the results
have been inconsistent so far (Johnson & Taliaferro, 2011). A
recent prospective study in older adults demonstrated reciprocal
inverse relationships between PA and depressive symptoms (Lind-
wall, Larsman, & Hagger, 2011). They found that there was a
stronger relationship between PA predicting later depressive
symptoms than between depressive symptoms predicting later
engagement in PA. We also have reported reciprocal prospective
associations between PA and depressive symptoms in a cohort of
Dutch adolescents (Stavrakakis, de Jonge, Ormel, & Oldehinkel,
2011). Associations were measured using a cross-lagged path
analysis model involving three measurements. The associations
found were significant but rather weak, indicating a high
amount of unexplained variance. Part of this unexplained vari-
ance may be because of individual differences in both the
potential benefits of PA in alleviating depressive symptoms and
the negative effects of depressive symptoms on PA levels. A
better understanding of these individual differences is needed to
design effective interventions for treating affective disorders.
We hypothesized that the plasticity genes might underlie part of
the assumed individual differences in the reciprocal associations
between PA and depressive symptoms. In their review, Belsky and
Pluess (2009), proposed a theoretical framework in which they
suggest that these individuals might have lower thresholds for
experiencing pleasure and/or displeasure that might result in dif-
ferential susceptibility to environmental influences. Although this
is speculative, two major neurobiological mediating mechanisms
have been identified, namely the serotonergic (experience of dis-
pleasure) and dopaminergic systems (reward sensitivity and sen-
sation seeking). These two systems have been implicated in the
etiology of depression (Lapin & Oxenkrug, 1969; van Praag &
Korf, 1970) but also have been shown to be influenced by PA
(Dishman et al., 2006). Alterations in serotonin and noradrenaline
levels have been suggested to be the main reason for the beneficial
effects of PA on stress-resilience and mood (Dishman et al., 2006).
Evidence for an effect of PA on the dopaminergic system comes
mainly from animal research where treadmill running increased
the release (Meeusen, Piacentini, & De Meirleir, 2001) and turn-
over of dopamine (Hattori, Naoi, & Nishino, 1994) in the striatum
of rats. Increasing dopamine levels is known to be an effective way
to improve mood (Lemke, Brecht, Koester, & Reichmann, 2006).
Therefore, these plasticity genes might modify the reciprocal as-
sociation between PA and depressive symptoms through their
differential action on the serotonergic and dopaminergic systems.
To date, only three studies have tried to elucidate whether
specific genotypes may be associated with the effects of PA on
depressive symptoms in humans. Rethorst, Landers, Nagoshi, and
Ross (2010) showed that after 30 min of exercise, carriers of a long
allele of the 5-HTTLPR exhibited greater reduction in depressive
symptoms than individuals with two short alleles. In a cross-
sectional study, Rethorst, Landers, Nagoshi, and Ross (2011)
demonstrated that the 5-HTTLPR gene modified the relationship
between PA and depressive symptoms in a sample of 170 students.
Finally, Mata, Thompson and Gotlib (2010) conducted a study in
adolescent girls, and found that PA involvement reduced depres-
sive symptoms in carriers of the Brain Derived Neurotrophic
Factor (BDNF) met allele, but not in carriers of the val/val poly-
morphism. BDNF is a growth factor which is encoded by the
BDNF gene and is abundant throughout the human body. Belsky et
al. did not include the BDNF gene in their list of plasticity genes.
However, because BDNF seems to be related to both PA (Goekint
et al., 2010; Knaepen, Goekint, Heyman, & Meeusen, 2010) and
depressive symptoms (Hashimoto, 2010; Verhagen et al., 2010),
the BDNF gene was considered a plausible modifier of the recip-
rocal association between PA and depressive symptoms, and there-
fore was included in our study as well.
The aim of the present study was to investigate whether plas-
ticity genes modified the reciprocal prospective associations be-
tween PA and depressive symptoms for several reasons. First, it is
important to extensively test robustness of gene environment in-
teractions (G  E), as this field seems to be plagued by noncon-
firmations. For example, the G  E between the short 5-HTTLPR
allele and adversity on depression first reported by Caspi, Hariri,
Holmes, Uher, and Moffitt (2003) has not been confirmed in two
meta-analyses (Munafo, Durrant, Lewis, & Flint, 2009; Risch et
al., 2009), but has been justified in a later qualitative review (Caspi
et al., 2010) and in the most recent meta-analysis (Karg, Burmeis-
ter, Shedden, & Sen, 2011) . Thus, for the advancement in the field
of G  E regarding PA and depressive symptoms, confirmation
studies are of utmost importance. Second, previous investigations
focused only on the unidirectional effects of PA on depressive
symptoms (Mata et al., 2010; Rethorst et al., 2010; Rethorst et al.,
2011). We extend this line of research by investigating possible
G  E in the reciprocal association between PA and depressive
symptoms using previously developed cross-lagged models in a
multigroup analysis. Third, we extend the G  E literature regard-
ing PA and depressive symptoms by using an index of cumulative
plasticity (Belsky & Beaver, 2011; Belsky et al., 2009; Belsky &
Pluess, 2009). Summarizing, in order to test whether the associa-
tions between PA and depressive symptoms were moderated by
genetic polymorphisms, we performed multigroup analyses with
regard to both cumulative plasticity index and individual polymor-
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Methods and Materials
Design
Data were used from the TRacking Adolescents’ Individual
Lives Survey (TRAILS), a prospective cohort (three assessment
waves) of Dutch adolescents. Permission for the study was ob-
tained from the Dutch Central Committee on Research Involving
Human Subjects. Further information on TRAILS objectives, main
design, data collection, sample selection, and nonresponse can be
found elsewhere (de Winter et al., 2005; Huisman et al., 2008).
Parents gave informed consent in the first wave, while for the
second and third wave informed consent was obtained from both
the parents and the participants themselves.
Procedure
During the first assessment wave, parents or guardians were
visited by TRAILS interviewers in their homes and were admin-
istered an interview. In addition, they were also asked to complete
a questionnaire. During the second and third wave, parents had to
complete a questionnaire which was sent through the mail. The
adolescents filled out self-report questionnaires at school. Further
information on TRAILS procedures can be found elsewhere (de
Winter et al., 2005; Huisman et al., 2008).
Participants
In the first assessment wave (T1) 2,230 adolescents from a
possible 2,935 (51% girls, mean age  11.08, SD  0.59) agreed
to take part in TRAILS. The response rates at the second wave and
third wave were 96.4% (N  2,149; 51% girls, mean age  13.65,
SD  0.53) and 81.4% (N  1,816; 53.2% girls, mean age 
16.27, SD  0.73) respectively. For the present study only partic-
ipants with complete genetic data were included (N  1,196,
52.3% girls). Individuals that did not have both parents born in the
Netherlands were also excluded from the final analysis, because
these single-nucleotide polymorphisms (SNPs) can differ between
ethnic groups. This focus sample was still representative of a
normal population of adolescents and the problems observed
therein.
Measures
Depressive symptoms. Adolescents filled out the Affective
Problems scale of the Youth Self Report (Achenbach, 1991b) for
each assessment wave at school. Parents completed the parent
version of the YSR the Child Behavior Checklist (Achenbach,
1991a) at home. The mean scores of the YSR and CBCL scales
were used in the analyses. The Affective Problem scale contains 13
items which correspond to Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition (DSM–IV) depressive symptoms
(van Lang, Ferdinand, Oldehinkel, Ormel, & Verhulst, 2005).
These items include sadness, loss of pleasure, crying, self-harm,
suicidal ideation, feelings of worthlessness, guilt, loss of energy,
overtiredness, eating problems, and sleeping problems; and are
scored on a 3-point scale (0  never or not at all true, 1 
sometimes true, and 2  very often or very true). One of the sleep
items (“I sleep more than most kids”) was excluded because
exclusion of this item increased the internal consistency of the
scale (Bosch et al., 2009). Scores on the remaining 12 items were
averaged to construct a total Depressive symptoms scale with an
internal consistency (Cronbach’s alpha) of 0.74 at T1, of 0.81 at
T2, and 0.86 at T3.
PA. At T1 adolescents were asked to rate how many times per
week they performed physical exercise (e.g., swimming, playing
football, horse-riding) on a 5-point scale (0  never, 1  once per
week, 2  two to three times per week, 3  four to five times per
week, and 4  five to six times per week). At T2 and T3, separate
questions were asked for PA during the summer and the winter:
“How many days in an average week in the summer/winter do you
take part in physical activities?” and the responses were scored on
an 8-point scale (0  never to 7  seven days per week). The
answers to these two questions were averaged, and mean scores
were used in the analysis. T1 responses (ranging from 0–4) were
recoded into an 8-point scale using the monotonic R7 transform
recommended by Little to achieve a similar metric for the PA
measures at all measurement waves (Little, in press).
Plasticity Genes
The list of plasticity genes as proposed by Belsky and Pluess
(2009) include DRD2, DRD4, 5HTTLPR, MAOA, TPH1,
5-HTR2A, COMT, and the DAT1. In our study, DAT1 was ex-
cluded because it was not genotyped, while the BDNF gene was
included for reasons explained in the Introduction. Following the
criteria set by Belsky and Pluess (2009), the A1 allele of DRD2,
the long version of DRD4 (from 7 repeats to 10 repeats), the short
allele of 5-HTTLPR, the 2R/3R alleles of MAOA, the A allele of
TPH1, the T allele of the 5-HTR2A, the val (G) allele of COMT,
and the met allele of BDNF were defined as plasticity alleles.
DNA Extraction
Blood samples (n  1,190) or buccal swabs (Cythobrush) (n 
275) were collected for DNA extraction using a manual salting out
procedure as described by Miller, Dykes, and Polesky (1988).
Genotyping of BDNF, DRD2, COMT, TPH1, and
5-HTR2A
The BDNF SNP (rs6265), DRD2/TaqIA (rs1800497), COMT/
val158met (rs4680), TPH1 (rs179913), and 5-HTR2A (rs6313) were
genotyped on the Golden Gate Illumina BeadStation 500 platform
(Illumina, San Diego, CA) according to the manufacturer’s protocol.
Call rates were: 81% for BDNF, 100% for DRD2, 95% for COMT,
100% for TPH1, and 100% for 5-HTR2A. All DNA samples could be
amplified, and concordance between DNA replicates (n  53)
showed a 100% genotyping accuracy (Nederhof et al., 2010). Data
cleaning was completed according to recommended procedures (Step-
toe, 2010). All SNPs were well within Hardy-Weinberg equilibrium,
with HWE p values ranging between .42 and .52.
Genotyping Length Polymorphisms of 5-HTTLPR,
DRD4, and MAOA
Genotyping of the length polymorphisms (LP) DRD4, MAOA,
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the Research lab for Multifactorial Diseases within the Human
Genetics department of the Radboud University Nijmegen Medical
Centre in Nijmegen, The Netherlands. Genotyping of the HTTLPR
polymorphism in the promoter region of SLC6A4 (5-HTT, SERT)
gene was performed by simple sequence length analysis. Call rate
was 91.6%. A custom-made TaqMan assay (Applied Biosystems)
was utilized to genotype the single nucleotide substitution (A to
G), which is present in the HTTLPR long (l) allele (rs25531). Call
rate was 96.5%. Concordance between DNA replicates showed an
accuracy of 100%. All lg alleles were recoded into s’, because it
has been shown that this polymorphism represents low serotonin
expression comparable to the s’ allele, while la was recoded as l’
(Nederhof et al., 2010). The 48 bp direct repeat polymorphism in
exon 3 of DRD4 was genotyped on the Illumina BeadStation 500
platform (Illumina.). Three percent blanks as well as duplicates
between plates were taken along as quality controls during geno-
typing. Determination of the length of the alleles was performed by
direct analysis on an automated capillary sequencer (ABI3730,
Applied Biosystems, Nieuwerkerk a/d IJssel, The Netherlands)
using standard conditions. Call rate for DRD4 was 99.4%. The
30bp variable number of tandem repeat polymorphism (called
MAOA-LPR or MAOA-uVNTR) was also genotyped on the Illu-
mina BeadStation 500 platform. Three percent blanks as well as
duplicates between plates were taken along as quality controls
during genotyping. Call rate was 100% for MAOA. All polymor-
phisms were well within Hardy-Weinberg equilibrium (HWE p
values ranged from 0.77 to 0.87).
Cumulative Genetic Plasticity Index
Each polymorphism was assigned one point if a plasticity ge-
notype was present and these values were summed to create a
cumulative index. Girls who were heterozygous for the MAOA
gene, which is located on the X chromosome, were categorized
into the low activity (i.e., high plasticity) genotype as proposed by
Belsky et al. (Belsky & Beaver, 2011). Three groups were created
according to the number of plasticity genotypes present: a low
group (high plasticity in 0–3 genes), intermediate group (high
plasticity in 4–5 genes), and a high group (high plasticity in 6–8
genes). Initially, the low group was defined as individuals carrying
0 to 1 plasticity genotypes, but because of insufficient power (n 
22) we merged this group with the individuals carrying two or
three plasticity genotypes. The three groups were of unequal size,
with the intermediate group having the most individuals. We
expected the intermediate group to be the most heterogeneous with
regard to each of the individual genes, therefore we deemed
necessary to create relatively equally sized groups for the high and
lowest plasticity groups.
Covariates
Gender and socioeconomic status (SES) were included as co-
variates. Five standardized variables (professional occupation and
educational attainment for both father and mother, and household
income) were averaged and used to calculate SES. The lowest 25%
of scores were considered as “low SES,” the highest 25% as “high
SES,” and the remaining were grouped as “intermediate SES.”
Analysis
Imputation of missing data. A detailed account of attrition
rates within the TRAILS study can be found elsewhere (Huisman
et al., 2008). Multiple imputations were performed for all variables
except for the missing genotyping data (N  1,196 at all three
measurement waves) using STATA version 10 (STATA corp.,
College Station, TX). Five different datasets (Rubin, 1996) were
created and were subsequently imported into Mplus 5 (Muthén &
Muthén, 2007) to be used in the analysis.
Cross-lagged path model. A cross-lagged path model (Struc-
tural Equation Modeling) using Mplus was created to investigate
cross-sectional and prospective associations between PA and de-
pressive symptoms. Using this model we estimated the direction of
the prospective effect (cross-lagged) between PA and depressive
symptoms but also the autoregressive paths (relative stability over
time) and the cross-sectional covariances (interpreted as correla-
tions at T1 and as correlated change at T2 and T3). Correlated
change and cross-lagged paths reflect longitudinal relationships.
Because of positive skewness of the depression variables, they
were log transformed prior to analysis. The cross-lagged path
model was also adjusted for gender and SES. A Comparative Fit
Index (CFI) and Tucker-Lewis Index (TLI) greater than 0.95 and
a Root Mean Square Error of Approximation (RMSEA) lower than
0.05 were considered a good model fit.
Cumulative plasticity index and individual genes
comparisons. A cross-lagged path model was specified for the
three groups based on the cumulative plasticity index. To test
whether there was a group difference in the reciprocal associations
between PA and depressive symptoms, we compared a model
where the cross-sectional paths at T1 and the cross-lagged paths
were constrained to be equal between groups with a model where
these paths were allowed to differ. To test whether the individual
polymorphisms affect the reciprocal association between PA and
depressive symptoms a similar design was used for each of the
individual genes. A 2 difference test was performed to test
whether the differences between the models reached statistical
significance. To avoid possible chance findings because of multi-
ple testing, a significant 2 difference score at the .01 level was
considered a significant difference between groups.
Results
Descriptive Statistics
Descriptive statistics of the main variables used in this study are
shown in Table 1. Both depressive symptoms and PA remained
stable over time. Frequencies for the cumulative plasticity index
and the frequencies for the different genotypes in individual genes
are shown in Table 2.
Relationships Between Depression and PA
Relationships between the total Depressive symptoms score and
PA are shown in Figure 1 (overall model fit, 2  6.445, p  .05,
df 6). Fit indices showed an excellent fit of model (CFI 0.999,
TLI  0.999, RMSEA  0.008), which was significantly better
than the fit of the model without cross-lagged paths from PA to





































































































788 STAVRAKAKIS ET AL.
the model without cross-lagged paths from depressive symptoms
to PA (2 difference  8.333, df  1, p  .05). As in our previous
article with more participants, all cross-lagged paths were signif-
icant, indicating that depressive symptoms at any wave predicted
PA at the next and vice versa. The autoregressive estimate of
depression was higher than the autoregressive estimate of PA. The
cross-sectional association (and correlational change) between PA
and depression was significant at all assessment waves.
Multigroup Analysis
The multigroup analysis for the three different putative plastic-
ity groups (low, intermediate, and high) is shown in Table 3.
Because the middle group was expected to be more heterogeneous
with regard to each of the individual genes, we first compared the
highest group against the lowest group (2 unconstrained 9.456,
df  12, 2 constrained  16.897, df  16) and then compared all
groups with each other (2 unconstrained  16.709, df  18, 2
constrained  24.728, df  26). The fit indices for both models
were excellent (CLI  .998, TLI  .995, RMSEA  .015). As
seen in Table 3, the 2 difference test was not significant at the .01
level.
Individual Polymorphisms
We carried out the same multigroup analysis approach for each
of the individual polymorphisms, comparing the putative plasticity
alleles against the nonplasticity alleles. Table 3 depicts the 2
difference test for each individual polymorphism. No significant
differences were found, just a trend (p  .03) for MAOA.
Discussion
The results of this study demonstrate reciprocal associations
between PA and depressive symptoms consistent with previous
studies (Lindwall et al., 2011; Stavrakakis et al., 2011) in larger
samples. This suggests that early engagement in PA precedes a
decrease in later depressive symptoms and vice versa.
This was the first study using a cumulative plasticity index as
proposed by Belsky et al. as a moderator in the association be-
tween PA and depressive symptoms. According to Belsky and
Pluess, the cumulative plasticity index assumes an additive effect
of these genes, where the susceptibility to environmental influ-
ences is hypothesized to increase with increasing numbers of
plasticity alleles. These genes play a role, through the translation
and transcription of specific proteins, in the formation and degra-
dation of serotonin and dopamine. Both of these neurotransmitters
are affected by PA and physical inactivity. They also have been
implicated in the etiology of depression, therefore making them
primary candidates for modifying the reciprocal association be-
tween PA and depressive symptoms. However, in the current
study, we did not find support for any modifying effects of the
Table 1
Means (SD) of the Main Variables Used in This Study (N  1,196)
T1 (mean age  11.1) T2 (mean age  13.5) T3 (mean age  16.3)
Total depressive symptoms 0.21 (0.19) 0.19 (0.21) 0.21 (.25)
Physical activity 3.52 (2.09) 3.38 (1.68) 3.51 (1.85)
Table 2
Frequencies of the Plasticity Index and Individual Genes
Groups (N  1,196)
Low group (0–3 plasticity alleles) Intermediate group (4–5 plasticity alleles) High group (6–8 plasticity alleles)
Plasticity index 28.7% 52.6% 18.7%
Individual genes Genotype distribution (%)
BDNF Val/Val Val/Met Met/Met
62.5% 34.4% 3.1%
DRD2 G/G A/G A/A
63% 33% 4%
COMT A/A A/G G/G
30.2% 50.1% 19.7%
DRD4 s/s s/l l/l
63% 32.3% 4.7%
5-HTR2A C/C C/T T/T
41% 44.6% 14.4%
5-HTTLPR l/l l/s s/s
26.2% 50% 23.8%
TPH1 C/C C/A A/A
36.5% 48.7% 14.8%
MAOA girls (n  625) High Intermediate Low
19.4% 55.2% 25.4%
MAOA boys (n  571) High Low N/A
37.1% 62.9%





































































































789GENES, PHYSICAL ACTIVITY, AND DEPRESSIVE SYMPTOMS
cumulative plasticity index on the associations between PA and
depressive symptoms.
We then proceeded in investigating the role of individual poly-
morphisms on the association of PA and depressive symptoms. To
date, there are only three published studies investigating modifying
effects of specific individual polymorphisms on the association
between PA and depressive symptoms (Mata et al., 2010; Rethorst
et al., 2010; Rethorst et al., 2011). The two studies by Rethorst and
colleagues investigated the 5-HTTLPR polymorphism, while the
study by Mata and colleagues investigated the BDNF polymor-
phism. All three studies found an influence of specific genotypes
(the carriers of met allele for BDNF and the carriers of the short
allele for 5-HTTLPR) on the relationship between PA and depres-
sive symptoms. None of these findings were confirmed in our
study. Both the BDNF and 5-HTTLPR genotypes as well as the
other individual genes that we investigated did not modify the
reciprocal association between PA and depressive symptoms in
our sample.
This lack of modifying effect could be down to a number of
reasons. First, perhaps these plasticity genes are not influencing
the relationship between PA and depressive symptoms at all,
contrary to our expectations. It is possible that other genes acting
on different neurotransmitter systems, such as the endorphin sys-
tem (Fox, 1999; Hegadoren, O’Donnell, Lanius, Coupland, &
Lacaze-Masmonteil, 2009) or the endocannabinoid system
(Sparling, Giuffrida, Piomelli, Rosskopf, & Dietrich, 2003), might
be playing a more important role in influencing the relationship
between PA and depressive symptoms. Second, it is possible that
plasticity genes play a role on the association between PA and
depressive symptoms but the design chosen in this study was not
appropriate to reveal these effects. This could be either because of
measurement error (see later section on strengths and limitations
for further information) or because the measurement waves were
not close enough to capture the processes involved in the interre-
lationships of plasticity, PA and depressive symptoms. In animal
research the ability to remain active (through free wheel running)
is thought to be an enriching environment with numerous benefits
on behavior and physiology. In humans, PA can be considered a
supportive or an enriching experience, especially when individuals
start exercising from a very early age and find it a pleasurable
experience, but that is still a matter of debate. In our study, we did
not find an effect of early engagement in exercise (at the age of 12)
on depressive symptoms and vice versa in individuals carrying
more plasticity genotypes compared to individuals carrying less.
However, to investigate this plasticity theory in depth, the effects
of even earlier (early childhood) exercise participation on depres-
Table 3
Multigroup Analysis Comparing the Three Different Cumulative Plasticity Groups (Low, Intermediate, and High) and Individual
Polymorphisms
2diff  2con.  2uncon. df diff  df con.  df uncon. p
Polymorphism
Cumulative plasticity (high vs. low of 3 groups) 7.44 4 .11
Cumulative plasticity (3 groups) 8.02 8 .43
Individual polymorphisms
BDNF 3.03 4 .55
5-HTTLPR 7.12 4 .13
DRD2 2.50 4 .64
MAOA 10.75 4 .03
5-HTR2A 3.64 4 .46
COMT 5.82 4 .21
DRD4 4.23 4 .38






























Figure 1. Associations between depressive symptoms and physical activity (PA) over time. The path coeffi-
cients reflect model estimated standardized beta values. The effects are adjusted for gender and socioeconomic
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sive symptoms should be investigated in individuals carrying these
plasticity genotypes. Finally, the exact functioning of certain poly-
morphisms is not entirely clear. For example, with respect to the
TPH1 gene previous studies have produced mixed results of which
allele might be acting as the plasticity allele. Belsky et al. (2009)
assumed that carrying the A allele is the putative plasticity geno-
type while other studies have suggested that the A allele might be
playing a protective role against MDD irrespective of positive
environmental influences (Viikki et al., 2010). MAOA is another
example of this complexity. The MAOA gene is only found at the
X chromosome, which makes the grouping of females more trou-
blesome than the grouping for males.
Further research on the exact function of these genes on the
neurotransmitter systems and the effects of exercise on the human
biology is needed in order to discover important genetic and
biological markers of the association between PA and depressive
symptoms. Epistatic interactions (gene-gene) must be also studied
extensively. Although studies on epistasis might be complicated
and difficult to conduct, the results might be informative in relation
to individual differences behind the reciprocal associations be-
tween PA and depressive symptoms.
There are some notable strengths in this study. First, the sample
size which was considerably larger than previous studies men-
tioned. Second, the longitudinal design (3 measurements) allowed
for the detection and investigation of changes between PA and
depressive symptoms over a long period of time (6 years). Finally,
the model fit was excellent, modeling the reciprocal relationship
between PA and depressive symptoms in our data with great
accuracy.
However, there are also limitations. First, most of the analysis
relied on self-reports. Self-reports are not as reliable as more
objective measurements of PA, such as, calculation of Metabolic
Equivalent of Task (METs) in minutes by accelerometers. In
addition, PA was assessed by a single question which was slightly
different at T1 than at the last two waves, unlike validated PA
questionnaires (e.g., IPAQ) which include a series of detailed
questions of PA involvement. At T2 and T3 separate questions for
winter and summer were asked and more response categories were
used compared to T1. Moreover, information on the nature
(leisure-time, voluntary or spontaneous), intensity or duration of
PA were not collected. This type of information may prove useful
for a better understanding of the influence of specific genes on the
association between PA and depressive symptoms, since different
types, intensities and durations of PA have been shown to be
differentially associated with depressive symptoms. Furthermore,
because of insufficient power, we merged the group without any
plasticity alleles (n  22) with the group carrying one to three
alleles, probably leading to some information loss. Finally, it
would be optimal to investigate changes in neurotransmitter levels
as a result of engaging in PA or increases/decreases in depressive
symptoms before investigating genetic modification, in order to
advance the knowledge of how these effects (PA and depressive
symptoms) affect human biology.
In conclusion, although gene-environment and studies on epis-
tasis can produce conflicting results and seem overly complicated,
there is still optimism that these studies can shed light on important
genetic factors which might explain individual differences in the
associations between PA and depressive symptoms. This elucida-
tion of genetic differences between individuals is necessary for
designing effective treatments for affective disorders. However, at
this time we did not find support for the notion that plasticity genes
may moderate the reciprocal association between depressive
symptoms and PA.
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